A patented platform technology that uses soil protists to actively transport agrochemicals through soil and concentrate them at growing root tips. Enables lower application rates, reduces environmental and safety concerns, and unlocks new delivery methods for high-cost, low-mobility crop protection agents.
This patented platform technology leverages naturally occurring soil protists—single-cell eukaryotic microorganisms—to actively transport agrochemical agents through soil and concentrate them at the tips of growing roots. Many promising agrochemicals suffer from poor soil mobility, high specific cost, and the need for excessive application rates, which limits viable delivery methods and creates health, safety, and environmental concerns. By harnessing protists as living delivery vehicles, the technology enables targeted rhizosphere delivery, potentially reducing application rates while expanding the range of agrochemicals that can be applied via seed treatment or other low-volume methods.
Core mechanism:
Validation evidence to date:
Planned next steps:
The platform has been demonstrated at the laboratory scale with model particles (beads) and living microbes (nitrogen-fixing bacteria), and intellectual property protection has been secured through an issued patent. The next logical step—validation with actual agrochemical particles—has been defined but not yet executed. The technology is positioned for collaborative development with agrochemical companies and seed-treatment formulators interested in expanding the applicability of high-value but mobility-limited crop protection products.
UConn is a comprehensive public research university and the state’s flagship, with its main campus in Storrs and an academic medical center in Farmington. Industry engages through UConn Tech Park—anchored by the Innovation Partnership Building—with shared labs, pilot‑scale testbeds, and advanced prototyping for collaborators. Integration with UConn Health enables clinical collaborations and translation, while Hartford and Stamford campuses connect companies to talent along the New York–Boston corridor; a statewide extension network supports technology adoption. Research is supported by competitive federal funding from agencies such as NIH, NSF, DOE, USDA, and DOD. A dedicated technology commercialization office and the Technology Incubation Program support IP, licensing, and startup incubation across multiple sites.